Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Mesothelioma × Radiation × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1 Other solid neoplasm 1

Conditions

Carcinoma, Non-Small-Cell Lung 12 Glioblastoma 10 Lung Neoplasms 9 Breast Neoplasms 9 Rectal Neoplasms 8 Head and Neck Neoplasms 7 Neoplasm Metastasis 6 Squamous Cell Carcinoma of Head and Neck 5 Sarcoma 5 Prostatic Neoplasms 5 Neoplasms 5 Brain Neoplasms 5 Leukemia 4 Gliosarcoma 4 Uterine Cervical Neoplasms 3 Urinary Bladder Neoplasms 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Pancreatic Neoplasms 3 Leukemia, Myeloid, Acute 3 Carcinoma, Squamous Cell 3 Carcinoma, Merkel Cell 3 Adenocarcinoma Of Esophagus 3 Xerostomia 2 Waldenstrom Macroglobulinemia 2 Small Cell Lung Carcinoma 2 Recurrence 2 Myelodysplastic Syndromes 2 Mycosis Fungoides 2 Mucositis 2 Melanoma 2

Interventions

Pemetrexed 8 pembrolizumab 6 Cisplatin 6 LMB-100 3 Carboplatin 3 Radiosurgery 2 Plicamycin 2 Dexamethasone 2 vandetanib 1 tremelimumab 1 tocilizumab 1 rebastinib 1 pevonedistat 1 perflutren 1 nintedanib 1 iodixanol 1 fludarabine phosphate 1 fludarabine 1 epacadostat 1 enzalutamide 1 durvalumab 1 defactinib 1 anetumab ravtansine 1 alvocidib 1 aldesleukin 1 Vinorelbine 1 Sulfur Hexafluoride 1 Radiotherapy, Intensity-Modulated 1 Radiation 1 Platinum 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01604005 2018-01-29

PIT

The Christie NHS Foundation Trust

Phase 3 Terminated

Other solid neoplasmThoracic

Mesothelioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡